Financial Consulate’s Zenas BioPharma ZBIO Stock Holding History

Financial Consulate’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.7K	Buy	+63	New	+$1.94K	﹤0.01%	1161

Other funds holding ZBIO

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Financial Consulate's ZBIO Position: Q3 2026 in Review

Financial Consulate opened a new position in Zenas BioPharma (ZBIO) in Q3 2026: 63 shares worth $1.7K. The stake represents ﹤0.01% of the portfolio and ranks #1161 among its holdings.

11 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

Financial Consulate held 63 shares of Zenas BioPharma worth $1.7K as of Q3 2026.
Zenas BioPharma was a new Financial Consulate position in Q3 2026.
Zenas BioPharma made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1161 holding.
11 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.